management of pulmonary disease
Last reviewed 06/2021
Treatment of respiratory disease is started early and aimed at prevention.
This is directed towards:
- bronchial clearance, in particular by vigorous daily physiotherapy, with
manual percussion, forced expiratory manoeuvres and vibration in a variety
of positions. There may also be a role for postural drainage - lying in a
variety of positions
- antibiotic treatment can be prophylactic and resposive.
- often lifelong to protect against Staph. aureus, the commonest childhood pathogen, Haemophilus inflenzae and Pseudomonas aeruginosa
- antibiotics may be intravenous, using a Port-a-Cath, or they may be nebulised and inhaled
- Pseudomonas becomes a major pathogen with increasing age
- Pseudomonas cepacia colonisation may be associated with accelerated lung disease
- Burkholderia cepacia complex (1)
- for people with cystic fibrosis who develop a new Burkholderia cepacia
complex infection (that is, recent respiratory sample cultures showed
no Burkholderia cepacia infection):
- whether they are clinically well or not, give antibiotic eradication therapy using a combination of intravenous antibiotics
- seek specialist microbiological advice on the choice of antibiotics
to use.
- for people with cystic fibrosis who develop a new Burkholderia cepacia
complex infection (that is, recent respiratory sample cultures showed
no Burkholderia cepacia infection):
- immunomodulatory agents (1)
- if deteriorating lung function or repeated pulmonary exacerbations, offer long-term treatment with azithromycin at an immunomodulatory dose
- if continued deterioration in lung function, or continuing pulmonary exacerbations while receiving long-term treatment with azithromycin, stop azithromycin and consider oral corticosteroids
- do not offer inhaled corticosteroids as an immunomodulatory treatment
for cystic fibrosis per se
- bronchodilators and steroids (oral or inhaled) may be beneficial in patients
with allergic bronchopulmonary aspergillosis
- mucolytics (DNA-ase) improve mucus expectoration
- mannitol dry powder for inhalation is recommended as an option for treating
cystic fibrosis in adults (2)
- exercise - anecdotal evidence that vigorous aerobic exercise slows lung
deterioration; it is said to improve bronchial clearance
- heart-lung transplantation is a final possibility
Reference:
treatment of haemophilus pneumonia
treatment of staphylococcal pneumonia
treatment of pseudomonas pneumonia
CF transmembrane conductance regulator (CFTR) modulators in cystic fibrosis (CF)